This Study is CLOSED to Enrollment!
Reason for the study
To see if an already in use medication called atropine sulfate used at a much lower concentration (0.01% and 0.02%) is effective at slowing nearsightedness progression in children
Why is this important
Nearsightedness (myopia) is becoming a more common problem in the United State and the rest of the world. High levels of nearsightedness are associated with vision-threatening problems such as retinal detachments and glaucoma.
Who is eligible
Nearsighted children between the ages of 3-10 years old. (The study is now closed to children ages 11-16 due to rapid enrollment)
Prescription between -0.50 and -6.00 units of nearsightedness (myopia) and less than 1.5 units of astigmatism
Who is involved
This a large randomized, controlled study involving 10 study sites throughout the country, including Eye Physicians of Central Florida. There will be approximately 500 children in the study.
Will my child benefit
Your child’s myopia may or may not progress during the study. The results of the study will be helpful for determining if this treatment is effective for nearsighted children
How long is the study and what is involved
The study will last for 4 years. Your child will be examined every 6 months. Study medication will need to be picked up every 3 months. Your child will be asked to place 1 drop in each eye before bed each night.
Other Important Points
There is no cost and no insurance needed for any eye examinations related to the study. There is compensation of up to $1,090 for the duration of the study and up to an additional $800 for any needed changes to glasses or contact lenses.
Principal Investigator: Dr. Louis C. Blumenfeld